ATE282407T1 - Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung - Google Patents

Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung

Info

Publication number
ATE282407T1
ATE282407T1 AT98944756T AT98944756T ATE282407T1 AT E282407 T1 ATE282407 T1 AT E282407T1 AT 98944756 T AT98944756 T AT 98944756T AT 98944756 T AT98944756 T AT 98944756T AT E282407 T1 ATE282407 T1 AT E282407T1
Authority
AT
Austria
Prior art keywords
coating preparation
medicinal coating
surfactant
polymer
medicinal
Prior art date
Application number
AT98944756T
Other languages
English (en)
Inventor
David E Edgren
Shu Li
Patrick S-L Wong
Gurdish Kaur Bhatti
Liang Chang Dong
Si-Hong Yum
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE282407T1 publication Critical patent/ATE282407T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AT98944756T 1997-09-09 1998-09-04 Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung ATE282407T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5826497P 1997-09-09 1997-09-09
PCT/US1998/018512 WO1999012526A1 (en) 1997-09-09 1998-09-04 Pharmaceutical coating composition and method of use

Publications (1)

Publication Number Publication Date
ATE282407T1 true ATE282407T1 (de) 2004-12-15

Family

ID=22015721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98944756T ATE282407T1 (de) 1997-09-09 1998-09-04 Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung

Country Status (9)

Country Link
US (1) US7087243B2 (de)
EP (1) EP1014951B1 (de)
JP (1) JP2001515855A (de)
AT (1) ATE282407T1 (de)
AU (1) AU9221898A (de)
DE (1) DE69827650T2 (de)
ES (1) ES2232021T3 (de)
PT (1) PT1014951E (de)
WO (1) WO1999012526A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
CN1893956A (zh) * 2003-07-25 2007-01-10 沃纳奇尔科特公司 多西环素金属络合物固体剂型
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US8080062B2 (en) * 2008-12-02 2011-12-20 Warsaw Orthopedic, Inc. Intervertebral implant with fixation mechanism
US8814912B2 (en) 2012-07-27 2014-08-26 Zimmer Spine, Inc. Bone stabilization member with bone screw retention mechanism

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3919436A (en) * 1971-09-27 1975-11-11 Eisai Co Ltd Process for preparation of coated medicines
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
JPS5157813A (en) * 1974-11-14 1976-05-20 Sankyo Co Ll dooba mataha sonojudotaiseizaino seiho
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4063064A (en) 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4117182A (en) 1976-12-23 1978-09-26 Commercial Decal, Inc. Heat release layer for decalcomanias
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4330338A (en) 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4217725A (en) * 1978-10-16 1980-08-19 Mattel, Inc. Combination doll and accessory articles
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4329451A (en) 1980-11-03 1982-05-11 The Dow Chemical Company Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5126146A (en) 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
EP0459516A1 (de) * 1990-06-01 1991-12-04 Kirin-Amgen, Inc. Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen
GB2258810B (en) * 1991-08-12 1996-01-31 Euro Celtique Sa Pharmaceutical combination formulation of diltiazem and hydrochlorothiazide
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
DE69425453T2 (de) 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
AU7345094A (en) * 1993-07-01 1995-01-24 Unilever Plc Oral compositions
KR100210509B1 (ko) 1996-01-10 1999-07-15 성재갑 지속성 동물 성장 호르몬 제형 및 이의 제조 방법

Also Published As

Publication number Publication date
US7087243B2 (en) 2006-08-08
DE69827650D1 (de) 2004-12-23
AU9221898A (en) 1999-03-29
WO1999012526A1 (en) 1999-03-18
ES2232021T3 (es) 2005-05-16
EP1014951A1 (de) 2000-07-05
EP1014951B1 (de) 2004-11-17
US20050003006A1 (en) 2005-01-06
DE69827650T2 (de) 2005-11-03
PT1014951E (pt) 2005-03-31
HK1029277A1 (en) 2001-03-30
JP2001515855A (ja) 2001-09-25

Similar Documents

Publication Publication Date Title
ATE202280T1 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
ATE221531T1 (de) Kristallmodifikation des cdch, verfahren zu dessen herstellung und diese enthaltende pharmazeutische zubereitungen
ATE231882T1 (de) 7alpha-(epsilon-aminoalkyl)-estratriene, verfahren zu deren herstellung, pharmazeutische präparate, die diese 7alpha-(epsilon-aminoalkyl)- estratriene enthalten sowie deren verwendung zur herstellung von arzneimitteln
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
ATE202703T1 (de) Pharmazeutische zusammensetzung zur oralen verabreichung von einem n-piperidin-3- pyrazolcarboxamid-derivat, dessen salzen und deren solvaten
MY112915A (en) Multiple unit tableted dosage form 1
ATE266422T1 (de) Pharmazeutische hydrogelformulierungen, vorrichtungen zur arzneistoffabgabe und verfahren
ATE228010T1 (de) Orale pharmazeutische dosierungsformen die einen protonenpumpeninhibitor und ein prokinetisches mittel enthalten
NO20064395L (no) Anvendelse av buprenorfin i fremstilling av et medikament
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
DE60019334D1 (de) Antivirale arznei
ATA900894A (de) Pharmazeutische kompositionen zum vorbeugen und heilen von krebserkrankungen und verfahren zu ihrer herstellung
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DE60301570D1 (de) 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE264332T1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
EP0683668A4 (de) Präparate und verfahren für eine transdermale arzneistoffverabreichung.
DE69827650D1 (de) Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
DE3868309D1 (de) Imidazol-derivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammenstellungen und deren anwendung als arzneimittel.
ATE353321T1 (de) Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahren,ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
BR9607169A (pt) Uso de meletonina e formulação farmacêutica para uso no tratamento de um viciado em drogas múltiplas
ATA67488A (de) Immunglobulinkonjugate, verfahren zu deren herstellung und anwendung sowie pharmazeutische mittel, die diese enthalten
EP1072261A3 (de) Felbinac enthaltendes Pflaster

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1014951

Country of ref document: EP

REN Ceased due to non-payment of the annual fee